- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.12.24 | Biosecure Act MIA from US defense bill in key win for China biopharma service providers | ||
| 09.12.24 | Amgen's Blincyto keeps 96% of pediatric leukemia patients alive and disease-free in 'practice changing' 3-year study | ||
| 09.12.24 | Merck gets rare win with Keytruda-Lynparza combo but role of Keytruda in ovarian cancer 'remains uncertain' | ||
| 09.12.24 | Omnicom, Interpublic ink merger to create world's largest ad agency | ||
| 09.12.24 | Acadia nabs Lexicon, Bristol Myers Squibb veteran as new commercial lead | ||
| 08.12.24 | ASH: AstraZeneca proposes fixed-duration Calquence combos in chronic lymphocytic leukemia | ||
| 06.12.24 | GSK's ViiV Healthcare encourages deeper conversations about life with HIV in video series | ||
| 06.12.24 | With green light from European Commission, Novo Holdings' proposed $16.5B Catalent buyout nears close | ||
| 06.12.24 | CDMO Resilience plots 105 layoffs at Florida plant it acquired in 2021 | ||
| 06.12.24 | Novo Nordisk slashes prices of additional insulin products but not until 2026 | ||
| 06.12.24 | Pfizer, Eli Lilly and PhRMA CEOs joined Trump for Mar-a-Lago dinner to talk collaboration, cures for cancer: Axios | ||
| 06.12.24 | Teva, Takeda sell generics joint venture in Japan to focus on innovative drugs | ||
| 06.12.24 | Employees' LinkedIn likes land AstraZeneca and GSK in hot water | ||
| 06.12.24 | PharmaEssentia nabs MorphoSys GM Horvat to lead its commercial team | ||
| 06.12.24 | AbbVie's Skyrizi retains DTC spending crown, as Novo's Wegovy sees first entry | ||
| 06.12.24 | Fierce Pharma Asia-Sanofi's $1B manufacturing base; GSK's ADC deal, Shingrix recalibration in China | ||
| 05.12.24 | On an investment spree, Lilly will spend $3B to expand newly acquired injectables plant in Wisconsin | ||
| 05.12.24 | Novartis' latest attempt to fend off MSN's Entresto generic falls short on appeal | ||
| 05.12.24 | AstraZeneca scores FDA nod for Imfinzi as first immunotherapy for limited-stage small cell lung cancer | ||
| 05.12.24 | GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal | ||
| 05.12.24 | Amgen rolls out $1B investment to build new drug substance plant in NC's biopharma hotbed | ||
| 05.12.24 | AstraZeneca chided by marketing watchdog after complainant aims allegations at senior staff | ||
| 05.12.24 | For first phase of Mounjaro's obesity rollout in England, only a limited number of patients will have access | ||
| 05.12.24 | FDA signs off on Merus' first-in-class NRG1+ cancer drug Bizengri after brief delay | ||
| 04.12.24 | Novo Nordisk keeps manufacturing expansion spree rolling with plans for $400M quality hub in Denmark |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
